Cell Separation Global Market Report 2024

The cell separation market size has grown rapidly in recent years. It will grow from $11.31 billion in 2023 to $13.21 billion in 2024 at a compound annual growth rate (CAGR) of 16.9%. During the historical period, the growth in cell separation techniques can be attributed to several factors, including the introduction of traditional separation methods, the emergence and adoption of innovative technologies such as flow cytometry and magnetic cell separation, the development of gradient separation techniques, and the early adoption of these methodologies within biomedical research.

The cell separation market size is expected to see rapid growth in the next few years. It will grow to $25.04 billion in 2028 at a compound annual growth rate (CAGR) of 17.3%. Anticipated growth in the upcoming period in cell separation techniques is expected due to several contributing factors, notably the integration of Artificial Intelligence (AI) and data analytics into cell separation methodologies, increased investments in research and development initiatives, a rising demand within the biopharmaceutical industry, and the escalation of stem cell research. Key trends projected in the forecast period encompass the utilization of microfluidic technologies, the emergence of novel and innovative cell separation techniques, a growing demand within the biotechnology and research sectors, a heightened focus on precision medicine approaches, and the implementation of automation and high-throughput processing methods in cell separation procedures.

The growth of the cell separation market is significantly influenced by the increasing number of patients suffering from cancer. Cancer is a severe disorder characterized by uncontrolled and rapid cell reproduction, leading to abnormal growth. In cancer treatment, cell separation plays a crucial role in isolating cancer tumor cells from normal cells for examination and treatment. For example, in September 2022, Cancer Australia reported an estimated 2,572 new cases of stomach cancer in Australia for the year. The rising incidence of cancer, such as stomach cancer, is expected to drive the demand for cell separation techniques, contributing to the growth of the market.

The cell separation market is anticipated to experience growth due to the increasing shift towards personalized medicine. Personalized medicine, also known as precision medicine, involves tailoring medical treatment to individual variations in patients' genes, environments, and lifestyles. This approach is likely to enhance cell separation procedures, allowing for more precise and individualized applications in biomedical and therapeutic fields. According to the Personalized Medicine Coalition's data from February 2023, personalized medicines accounted for 34% of new drugs approved by the US Food and Drug Administration in 2022. This trend indicates a growing reliance on personalized medicine, driving the demand for advanced cell separation techniques to support individualized medical approaches.

Technological advancements represent a key trend in the cell separation market. Major companies are investing in the development of innovative cell separation technologies to increase throughput and optimize processes, gaining a competitive advantage. For instance, Akadeum Life Sciences, a US-based biotechnology company, launched the Microbubble Leukopak Human T Cell Isolation Kit in September 2022. This kit utilizes buoyancy-based cell separation technology, combining microbubbles with a Buoyancy Activated Cell Sorting (BACSTM) Separation Tube. The innovative kit allows scientists to process larger volumes of leukopaks in significantly less time compared to traditional procedures, improving productivity and operational efficiency. The emphasis on technological advancements is expected to further propel the growth of the cell separation market.

Leading companies in the cell separation market are adopting a strategic partnership approach to enhance their offerings, particularly in the supply of reagent kits for cell separation. This strategic collaboration involves leveraging the strengths and resources of each partner to achieve mutual benefits and success. An illustrative example of this approach is the partnership announced in April 2022 between Applied Cells Inc., a US-based research and pharmaceutical manufacturing company, and STEMCELL Technologies Canada Inc., a Canadian biotechnological company. Applied Cells Inc. and STEMCELL Technologies are collaborating to provide a high-performance cell separation solution by combining Applied Cells' MARS technology with STEMCELL's EasySep immunomagnetic cell separation kits. This partnership aims to assist researchers globally by automating and improving the efficiency of separating high-quality cells from various sample types, including whole blood, bone marrow, apheresis products, and dissociated tissue. The integration of Applied Cells' MARS platform with STEMCELL Technologies' cell division reagents is positioned as a next-generation solution to address evolving cell separation requirements in the research industry.

In July 2022, Bio-Techne Corporation, a prominent US-based biotechnology company, adopted a strategic approach by acquiring Namocell Inc., a US-based biotechnology company, for an undisclosed amount. The acquisition includes innovative single-cell sorting and dispensing platforms, enhancing Bio-Techne Corporation's offerings in the cell separation market. Namocell's technology empowers single-cell research and therapeutics development, aligning with Bio-Techne Corporation's commitment to providing advanced solutions in the field.

Major companies operating in the cell separation market report are Becton, Dickinson and Company, Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Terumo Corporation, Miltenyi Biotec GmbH, Beckman Coulter Inc., STEMCELL Technologies Inc., PluriSelect Life Science UG and Co. KG, GE HealthCare Technologies Inc., Philips Healthcare Informatics Inc., Akadeum Life Sciences LLC, 10X Genomics Inc., Carl Zeiss AG, Life Technologies Inc., Danaher Corporation, Agilent Technologies Inc., Corning Incorporated, F. Hoffmann-La Roche Ltd., Alfa Laval AB, Sartorius AG, Bio-Techne Corp., PerkinElmer Inc., Invent Biotechnologies Inc., Takara Bio Inc., Lonza Group Ltd., Promega Corporation, MagBio Genomics, Akadeum Life Sciences Inc., MiCareo Inc., Proteintech Group Inc., QIAGEN NV.

North America was the largest region in the cell separation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the cell separation market report during the forecast period. The regions covered in the cell separation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell separation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary categories of cells used in cell separation processes include human and animal cells. Human cells represent the basic structural and functional units of the human body. Various methodologies are utilized for cell separation, including gradient centrifugation, surface marker separation, fluorescence-activated cell sorting, and magnetic cell sorting. Products associated with cell separation encompass consumables and instruments, facilitating applications such as biomolecule isolation, cancer research, stem cell research, tissue regeneration, in vitro diagnostics, and therapeutic development.

The cell separation market research report is one of a series of new reports that provides cell separation market statistics, including cell separation industry global market size, regional shares, competitors with a cell separation market share, detailed cell separation market segments, market trends and opportunities, and any further data you may need to thrive in the cell separation industry. This cell separation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.